Published customer image: . Mouse anti Chlamydia LPS antibody, clone CF 6J12 used for the detection of Chlamydia LPS in aortic lesions of Chlamydia infected mive by immunofluorescence. Image caption: . 1a. Agarose gel electrophoresis of PCR products (first stage, lanes 2–6; second stage, lanes 8–12). Lanes 2 and 3 using genomic DNA as a template from two Apobtm2SgyLdlrtm1Her/J mice infected with Cpn bacteria; lanes 5 and 6 using genomic DNA from two non-infected Apobtm2SgyLdlrtm1Her/J mice; lanes 8, 9, 11 and 12 using first-stage PCR products 2, 3, 5 and 6 as a template, respectively. Lanes 1 and 7 show the Phi174 DNA/HaeIII maker (Promega). 1b. Chlamydia LPS antibody (MCA 2718, Bio-Rad) stained lesion sites in aortic sinus. Chlamydia LPS antibody (MCA 2718, Bio-Rad) was used as the first antibody (10 mg/ml), anti-mouse IgG-FITC, developed in sheep, was used as a second antibody. Green represents Chlamydia LPS and blue represents cell nuclei stained with 4′,6-diamidino-2-phenylindole (DAPI) (Vector Lab, Peterborogh, UK) [N = 6 mice]. From: Xia M, Chen D, Endresz V, Faludi I, Szabo A, Gonczol E, et al. (2013) Immunization of Chlamydia pneumoniae (Cpn)-Infected Apobtm2SgyLdlrtm1Her/J Mice with a Combined Peptide of Cpn Significantly Reduces Atherosclerotic Lesion Development. PLoS ONE 8(12): e81056.